Koichi S Kobayashi
9PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jul 15, 2025
Bacterial Therapeutics: Addressing the Affordability Gap in Cancer Therapy.Kejsi Prifti, Chiswili Yves Chabu, Koichi S Kobayashi
|Mar 10, 2024
NLRC5/MHC class I transactivator: A key target for immune escape by SARS-CoV-2.Baohui Zhu, Ryota Ouda, Yusuke Kasuga
|Feb 01, 2024
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I.Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda
|Aug 21, 2023
ORF6, a repressor of the MHC class I pathway: new molecular target for SARS-CoV-2 drug discovery?Baohui Zhu, Ryota Ouda, Paul de Figueiredo
|Jun 06, 2023
FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.Yusuke Kasuga, Ryota Ouda, Masashi Watanabe
|Feb 15, 2022
Metabolomics of Acute vs. Chronic Spinach Intake in an Apc-Mutant Genetic Background: Linoleate and Butanoate Metabolites Targeting HDAC Activity and IFN-γ Signaling.Ying-Shiuan Chen, Jia Li, Sultan Neja
Pageof 2
Frequent Collaborators
2 joint publications
Yusuke Kasuga
1 joint publications
Sultan Neja
1 joint publications
Kyongbum Lee
1 joint publications
Roderick Dashwood
1 joint publications
Ji-Seung Yoo
1 joint publications
Michihito Sasaki
1 joint publications
Baohui Zhu
1 joint publications
Yasuko Orba
1 joint publications
Hirofumi Sawa
1 joint publications
Masashi Watanabe
